跳至主要内容
临床试验/NCT03248791
NCT03248791Unknown4 期

Comparison of Two Vasopressor Infusion for Prevention of Post-spinal Hypotension During Cesarean Delivery: A Randomized Controlled Trial

Cairo University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2017年8月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
120
试验地点
1
主要终点
incidence of post-spinal anesthesia hypotension

研究概览

简要总结

Comparison will be conducted between continuous variable infusions of both drugs (Phenylephrine and Norepinephrine) with starting doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against Post-spinal hypotension during cesarean delivery.

详细描述

Maternal hypotension is a common complication after spinal anesthesia for cesarean delivery (CD). Many vasopressors have been used for prevention of post-spinal hypotension (PSH) during CD; however, the optimum protocol for prophylaxis is not established yet. Phenylephrine (PE) is a popular vasopressor used in obstetric anesthesia; however, its use is limited by its marked cardiac depressant nature. Norepinephrine (NE) is a potent vasopressor characterized by both α adrenergic agonistic activity in addition to a weak β adrenergic agonistic activity; thus, NE is considered a vasopressor with minimal cardiac depressant effect; these pharmacological properties would make NE an attractive alternative to PE. In this study, we will compare continuous variable infusion of both drugs (PE and NE) with doses of 0.75 mcg/Kg/min and 0.1 mcg/Kg/min respectively for prophylaxis against PSH during CD.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • full term
  • pregnant women
  • scheduled for cesarean section

排除标准

  • pre-ecpamsia
  • eclampsia
  • cardiac dysfuction

研究组 & 干预措施

Phenylephrine

Active Comparator

Will receive spinal anesthesia using Bupivacaine. Then, phenylephrine infusion by a starting rate of 0.75 mcg/Kg/min. The rate will be then adjusted according to the patient blood pressure

干预措施: Phenylephrine (Drug)

Phenylephrine

Active Comparator

Will receive spinal anesthesia using Bupivacaine. Then, phenylephrine infusion by a starting rate of 0.75 mcg/Kg/min. The rate will be then adjusted according to the patient blood pressure

干预措施: Bupivacaine (Drug)

Norepinephrine

Experimental

Will receive spinal anesthesia using Bupivacaine. Then, norepinephrine infusion by a starting rate of 0.1 mcg/Kg/min. The rate will be then adjusted according to the patient blood pressure

干预措施: Norepinephrine (Drug)

Norepinephrine

Experimental

Will receive spinal anesthesia using Bupivacaine. Then, norepinephrine infusion by a starting rate of 0.1 mcg/Kg/min. The rate will be then adjusted according to the patient blood pressure

干预措施: Bupivacaine (Drug)

结局指标

主要结局

incidence of post-spinal anesthesia hypotension

时间窗: 30 minutes after spinal anesthesia

Defined as the percentage of patients with decreased systolic blood pressure less than 80% of the baseline reading

次要结局

  • incidence of severe post-spinal anesthesia hypotension(30 minutes after spinal anesthesia)
  • incidence of reactive hypertension(2 hours after spinal anesthesia)
  • incidence of severe delivery hypotension(10 minutes after delivery)
  • heart rate(2 hours after subarachnoid block)
  • APGAR score(10 minutes after delivery)
  • systolic blood pressure(2 hours after subarachnoid block)
  • diastolic blood pressure(2 hours after subarachnoid block)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Hasanin

Assistant professor

Cairo University

研究点 (1)

Loading locations...

相似试验